Literature DB >> 26580340

The Chinese herb extract Wenxin Keli: A promising agent for the management of atrial fibrillation.

Yang Liu1, Zhiwei Zhang1, Yajuan Yang1, Nixiao Zhang1, Guangping Li1, Tong Liu2.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Chinese herb; Wenxin Keli

Mesh：

Substances：

Year:  2015        PMID： 26580340     DOI： 10.1016/j.ijcard.2015.10.211

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  5 in total

1.  Molecular Targets and Pathways Contributing to the Effects of Wenxin Keli on Atrial Fibrillation Based on a Network Pharmacology Approach.

Authors:  Yujie Zhang; Xiaolin Zhang; Xi Zhang; Yi Cai; Minghui Cheng; Chenghui Yan; Yaling Han
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-07       Impact factor: 2.629

2.  An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation.

Authors:  Yuanping Wang; Yuntao Liu; Xia Yan; Dawei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-30       Impact factor: 2.650

Review 3.  Pharmacological Therapy in Brugada Syndrome.

Authors:  Oholi Tovia Brodie; Yoav Michowitz; Bernard Belhassen
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06

4.  Wenxin Keli for atrial fibrillation: Protocol for a systematic review and meta-analysis.

Authors:  Zhuogen He; Minan Zheng; Pingchang Xie; Yuanping Wang; Xia Yan; Dingwei Deng
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

5.  Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation.

Authors:  Nixiao Zhang; Gary Tse; Shristi Dahal; Yajuan Yang; Mengqi Gong; Calista Zhuo Yi Chan; Enzhao Liu; Gang Xu; Konstantinos P Letsas; Panagiotis Korantzopoulos; Guangping Li; Tong Liu
Journal:  Cardiol Res Pract       Date:  2018-12-04       Impact factor: 1.866
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.